Detail akcie GENOMTEC Br online

Business Summary: Genomtec SA is a Poland-based company engaged in biotechnology and medical research business sector and it is operating in the field of clinical diagnostics. The Company is focused on development of of Genomtec ID, a mobile platform for genetic diagnosis in the point of patient care. Its creation and commercialization allows the diagnostic process to be executed in point of care setting, such as: primary care clinics, pharmacies, doctor’s offices, hospital emergency departments (ERs) without the need for complicated and time-consuming laboratory workflow conducted by qualified personnel.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Genomtec SA revenues increased from PLN1K to PLN21K. Net loss decreased 7% to PLN10.4M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Lower net loss reflects Selling/General/Admin Expense decrease of 25% to PLN6.8M (expense), Grants increase of 94% to PLN4.5M (income).